Similar companies
Company | Transaction Value | |
---|---|---|
OcugenOCGN |
-$4.6M | |
AmarinAMRN |
$1.7M | |
Gilead SciencesGILD |
-$233M | |
Anavex Life SciencesAVXL |
-$14M | |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Thaysen Jacob | Feb 22, 2024 | Buy | 5,085 | $134.91 | $690,000 |
Thaysen Jacob | Feb 22, 2024 | Buy | 1,553 | $135.69 | $210,000 |
Thaysen Jacob | Feb 22, 2024 | Buy | 692 | $137.18 | $95,000 |
Hoyt Aimee L | Nov 7, 2023 | Sell | 315 | $112.84 | $36,000 |
TOUSI SUSAN H | Aug 22, 2023 | Sell | 500 | $167.04 | $84,000 |
TOUSI SUSAN H | Jul 24, 2023 | Sell | 500 | $190.08 | $95,000 |
TOUSI SUSAN H | Jun 22, 2023 | Sell | 500 | $200 | $100,000 |
TOUSI SUSAN H | May 22, 2023 | Sell | 1,676 | $209.67 | $350,000 |
TOUSI SUSAN H | May 22, 2023 | Sell | 1,618 | $207.75 | $340,000 |
TOUSI SUSAN H | May 22, 2023 | Sell | 1,506 | $208.7 | $310,000 |
TOUSI SUSAN H | May 22, 2023 | Sell | 200 | $205.63 | $41,000 |
Hoyt Aimee L | Mar 1, 2023 | Sell | 3,917 | $199.0649 | $780,000 |
Aravanis Alexander | Feb 22, 2023 | Sell | 3,078 | $201.42 | $620,000 |
Aravanis Alexander | Feb 22, 2023 | Sell | 2,320 | $202.16 | $470,000 |
TOUSI SUSAN H | Feb 6, 2023 | Sell | 500 | $211.57 | $110,000 |
Hoyt Aimee L | Jan 9, 2023 | Sell | 871 | $205.57 | $180,000 |
TOUSI SUSAN H | Jan 6, 2023 | Sell | 500 | $204.58 | $100,000 |
What's the latest insider transaction for Illumina?
The most recent insider transaction for Illumina was conducted by Thaysen Jacob, who sold 5,085 shares on February 22, 2024 at a price of $134.91 per share.
Which insider bought the most ILMN stock over the last two years?
Thaysen Jacob has bought the most ILMN stock in the last 2 years, with a total value of $990,000.
Which insider has sold the most ILMN stock over the last two years?
TOUSI SUSAN H has sold the most ILMN stock in the last 2 years, with a total value of $1.5M.
What is the total value of insider transactions for Illumina (ILMN) in the last 2 years?
The total value of insider transactions for Illumina in the last 2 years is negative, amounting to -$2.6M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Illumina's market confidence?
Over the last 2 years, insider transactions for Illumina have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.